4D pharma will present at the 2nd Annual Microbiome Discovery & Development Congress which takes place June 7 - 8 in Berlin. The company will provide an update on MRx0518, the company's lead live biotherapeutic candidate in the field of immuno-oncology, which is set to hit the clinic later this year across multiple therapeutic settings.
The presentation will be:
Live Biotherapeutics – From Concept To Clinic In Immuno-Oncology, presented by Imke Mulder, Research Director
Download the presentation here.
